U.S. health insurers came under pressure after the government proposed only a marginal increase in payments for Medicare Advantage plans in 2027, disappointing investors who had expected a stronger adjustment. The proposal calls for an average payment rise of just under one tenth of one percent, a level that fell well below market expectations given rising medical costs and utilization among older Americans. The announcement triggered a sharp selloff across major insurers, reflecting concerns that profitability could be squeezed if funding fails to keep pace with expenses. The reaction underscored the sensitivity of the sector to policy signals tied to public healthcare programs.
The proposed update factors in projected cost trends, quality ratings, and changes to how patient risk is assessed, a model that determines how much insurers are paid based on the health of their members. Officials said the approach is designed to improve efficiency while protecting taxpayers from excessive spending. Even so, analysts noted that the modest increase could materially affect earnings forecasts, particularly for companies with large exposure to Medicare Advantage. Shares of leading providers, including UnitedHealth Group and CVS Health, dropped sharply as investors reassessed revenue expectations for the coming year.
Industry participants said the proposal did not reflect the full extent of cost pressures facing insurers, particularly in senior care where utilization has remained elevated. Some analysts had anticipated a mid single digit increase to offset rising claims and administrative expenses. The proposed rates are expected to add hundreds of millions of dollars in aggregate payments, but critics argue that the increase remains insufficient when spread across the entire program. Insurers are expected to provide more detail on potential impacts when reporting earnings and updating guidance in the coming weeks.
The proposal now enters a consultation period ahead of a final decision expected later in the year. Industry groups have warned that if the rates are finalized without adjustment, insurers may be forced to scale back benefits or raise out of pocket costs for enrollees. Medicare Advantage covers more than half of all Medicare beneficiaries, making the outcome a critical issue for both companies and consumers. Markets are likely to remain sensitive to further signals from policymakers as the final framework takes shape.
